These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 8559484

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diagnosis and treatment of chronic lead poisoning in CAPD patients.
    Kessler M, Durand PY, Hestin D, Gamberoni J, Chanliau J.
    Adv Perit Dial; 1993; 9():143-6. PubMed ID: 8105909
    [Abstract] [Full Text] [Related]

  • 3. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL, Lin-Tan DT, Hsu KH, Yu CC.
    N Engl J Med; 2003 Jan 23; 348(4):277-86. PubMed ID: 12540640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of initial results of treatment of lead poisoning with EDTA].
    Petkova V, Adjarov D, Pavlova S, Naydenova E, Kerimova M, Kuneva T.
    Med Lav; 1994 Jan 23; 85(4):299-308. PubMed ID: 7808345
    [Abstract] [Full Text] [Related]

  • 6. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL.
    Am J Med; 2006 Aug 23; 119(8):707.e1-9. PubMed ID: 16887418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL, Lim PS.
    Miner Electrolyte Metab; 1992 Aug 23; 18(1):1-5. PubMed ID: 1406500
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL.
    Nephrol Dial Transplant; 2007 Oct 23; 22(10):2924-31. PubMed ID: 17556414
    [Abstract] [Full Text] [Related]

  • 10. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D, Mondaini G, Ravera F, Minisci E, Albertazzi V, Arletti S, Mori G, Ballestri M, Piattoni J, Cappelli G.
    G Ital Nefrol; 2007 Oct 23; 24 Suppl 38():76-9. PubMed ID: 17922453
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct 23; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
    Lin JL, Lim PS.
    J Hum Hypertens; 1994 Jul 23; 8(7):495-500. PubMed ID: 7932512
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.